Emi Kimoto
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 46
- Drug Transport and Resistance Mechanisms 43
- Pharmacology 34
- Pharmacogenetics and Drug Metabolism 27
- Drug-Induced Hepatotoxicity and Protection 7
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Manthena V. S. Varma (24 shared papers)Yurong Lai (9 shared papers)Yi‐An Bi (12 shared papers)A. David Rodrigues (12 shared papers)Anna Vildhede (6 shared papers)Ayman El‐Kattan (7 shared papers)Jian Lin (11 shared papers)Hidenori Koyama (3 shared papers)
- Journals
- Drug Metabolism and Disposition (16 papers)Clinical Pharmacology & Therapeutics (8 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)The AAPS Journal (3 papers)The Journal of Biochemistry (3 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Emi Kimoto
67 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 123
- Pharmacology 996
- Oncology 1.5k
- Pediatrics, Perinatology and Child Health 746
- Nephrology 280
- Transplantation 36
Countries citing papers authored by Emi Kimoto
This map shows the geographic impact of Emi Kimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Kimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Kimoto more than expected).
Fields of papers citing papers by Emi Kimoto
This network shows the impact of papers produced by Emi Kimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Kimoto. The network helps show where Emi Kimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Emi Kimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 291 | |
| 2 | 2003 | 280 | |
| 3 | 2012 | 201 | |
| 4 | 2003 | 174 | |
| 5 | 2006 | 137 | |
| 6 | 2012 | 92 | |
| 7 | 2019 | 83 | |
| 8 | 2013 | 83 | |
| 9 | 2022 | 83 | |
| 10 | 2013 | 74 | |
| 11 | 2019 | 68 | |
| 12 | 1993 | 66 | |
| 13 | 2018 | 63 | |
| 14 | 2011 | 60 | |
| 15 | 2019 | 58 | |
| 16 | 2015 | 58 | |
| 17 | 2014 | 57 | |
| 18 | 2012 | 52 | |
| 19 | 2017 | 51 | |
| 20 | 2018 | 48 |
About Emi Kimoto
Emi Kimoto is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Molecular Biology and Epidemiology, having authored 67 papers that have together received 2.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (43 papers), Pharmacogenetics and Drug Metabolism (27 papers), Pharmacological Effects and Toxicity Studies (20 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Glycosylation and Glycoproteins Research (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Pharmacology (996 citations), Oncology (1.5k citations), Pediatrics, Perinatology and Child Health (746 citations), Nephrology (280 citations) and Transplantation (36 citations). Emi Kimoto has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Manthena V. S. Varma, Yurong Lai, Yi‐An Bi, A. David Rodrigues, Anna Vildhede, Ayman El‐Kattan, Jian Lin, Hidenori Koyama, Maria Karlgren and Per Artursson. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, The AAPS Journal and The Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.